Axogen (NASDAQ:AXGN) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.07, beating the consensus estimate of $0.04 by $0.03 per share. Revenue came in at $59.9M, beating the estimate of $59.9M.
Axogen's stock moved following the earnings release. The stock currently trades at $31.52 with a market capitalization of $1.4B.


